Overview

Effects of Dengzhanxixin Capsule on Platelet Function in Individuals at High Risk for Cardiovascular Disease

Status:
Not yet recruiting

Trial end date:
2023-12-31

Target enrollment:

Participant gender:

Summary

The main objective of this clinical trial is to evaluate whether the antiplatelet efficacy of the Dengzhanxixin capsule is better than that of placebo in individuals at high-risk for atherosclerotic cardiovascular disease (ASCVD).

Phase:

N/A

Details

Lead Sponsor:

China National Center for Cardiovascular Diseases

Collaborator:

Fuwai Hospital, Chinese Academy of Medical Sciences, Shenzhen, Shenzhen